NASDAQ$MAZE
Maze Therapeutics Inc · Q2 2026 earnings
Q2 2026 earnings · · After market close
Reports in 4 weeks
Maze Therapeutics Inc hasn't published Q2 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- $20M
- EPS
- -$0.45
Year-ago · Q2 2025 Q2 2025
- Revenue
- $0.00
- EPS
- -$0.77
Revenue & EPS history
Maze Therapeutics Inc · Revenue · Quarterly
$20M
Q1 2026
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 2 quarterly earnings reports
+0.3%
Avg return
Earnings day
+2.4%
Avg return
5 days after
+38.8%
Avg return
30 days after
67%
2 / 3 earnings
Positive
+2.0%
Q2 2025
Best reaction
-2.1%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | +0.4% | -5.6% | |
| Q3 2025 | -2.1% | +6.6% | +37.8% | |
| Q2 2025 | +2.0% | +0.2% | +84.1% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro